Skip to main content
Clinical Trials/NCT04711473
NCT04711473
Completed
Not Applicable

Choice Architecture and Mailed Colorectal Cancer Screening Outreach in a Community Health Setting

Abramson Cancer Center at Penn Medicine1 site in 1 country800 target enrollmentOctober 27, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Colorectal Cancer
Sponsor
Abramson Cancer Center at Penn Medicine
Enrollment
800
Locations
1
Primary Endpoint
Colorectal Cancer Screening Completion
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

This is a 3-arm randomized trial aimed at increasing rates of participation in colorectal cancer (CRC) screening by outreach to patients' homes using choice architecture informed by behavioral science principles.

Detailed Description

The investigators will evaluate the effectiveness of mailed outreach with choice between colonoscopy and FIT, and FIT alone, as compared to colonoscopy alone in increasing CRC screening rates.

Registry
clinicaltrials.gov
Start Date
October 27, 2021
End Date
November 11, 2022
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Shivan Mehta

Principal Investigator

Abramson Cancer Center at Penn Medicine

Eligibility Criteria

Inclusion Criteria

  • At least 1 visit with CHDC in the past 2 years
  • Not up to date on CRC screening (no evidence of colonoscopy in the last 10 years, sigmoidoscopy in the last 5 years, or stool testing in the past 12 months)

Exclusion Criteria

  • History of CRC or polyps
  • Significant family history of CRC
  • History of Inflammatory Bowel Disease or Ulcerative Colitis
  • History of colectomy
  • History of metastatic cancer
  • Current use of Medication Assisted Therapy (MAT)

Outcomes

Primary Outcomes

Colorectal Cancer Screening Completion

Time Frame: 6 months from initial outreach

Screening completion rate in arm 2 (Choice) to arm 1 (Colonoscopy only) and arm 3 (FIT only) separately.

Secondary Outcomes

  • Choice of Colorectal Cancer Screening Test(6 months from initial outreach)

Study Sites (1)

Loading locations...

Similar Trials